REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion — RESTORE  

Stroke Clinical Trial

Official title: REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion

Status Recruiting

Clinical Trial Summary

The aim of the study was to establish a clinical and advanced imaging database of acute ischemic stroke patients treated with mechanical thrombectomy due to large vessel occlusion of anterior circulation within 24 hours from stroke onset in China, and to investigate the predictors and potential mechanisms of futile recanalization after mechanical thrombectomy.

Clinical Trial Description

The time-window of mechanical thrombectomy for ischemic stroke has extended from 4.5 hours to 24 hours based on the results of the DAWN and DEFUSE 3 trials. However, evidence on the effectiveness and safety of mechanical thrombectomy within 24 hours in the real-world is insufficient. This is a multi-center, prospective, registry cohort study that acute ischemic stroke patients treated with mechanical thrombectomy due to large vessel occlusion of anterior circulation within 24 hours from stroke onset in China. A retrospective dataset was also build in these stroke centers for analysis. A total of 1600 patients with advanced imaging data were anticipated to be enrolled. ;

Related Conditions & MeSH terms

• Endovascular Treatment
• Ischemic Stroke
• Mechanical Thrombectomy
• Perfusion Imaging
• Stroke
• Vascular Occlusion

• NCT number: NCT05311605
• Study type: Observational [Patient Registry]
• Source: Beijing Tiantan Hospital
• Contact: Yunyun Xiong, MD, PhD
• Phone: 00861059975213
• Email: xiongyunyun@bjtth.org
• Status: Recruiting
• Start date: February 23, 2023
• Completion date: December 31, 2024